Gamaleya Center has applied for permanent registration of "Sputnik V"

“Yes, they have ended, the documents have been submitted, and they are now being considered,” RIA Novosti quotes Gintsburg as saying.

The Ministry of Health of Russia on August 25 issued a permit to the Gamaleya Center for post-registration studies. 

Previously, director of the Research Center for Epidemiology and Microbiology named after V.I.

Gamalei Alexander Gintsburg spoke about the use of the "Sputnik Light" drug as part of the regular boosting of the existing immunity to combat the "delta" strain.